LIGAND PHARMACEUTICALS INC reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
LIGAND PHARMACEUTICALS INC has filed 2,284 SEC EDGAR filings since 13 Sep 1994

SEC filing history

Showing 376-400 of 1,000 matching filings.

Per page
25
Current page
16
4

FORM 4 SUBMISSION

Filing date
03 Nov 2022
Reporting date
01 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-33093

425

Filing date
03 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3 File 000-56427

FORM 3 SUBMISSION

Filing date
30 Sep 2022
Reporting date
30 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3ASR File 333-267678

S-3ASR

Filing date
30 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

PRIMARY DOCUMENT

Filing date
22 Sep 2022
Reporting date
16 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 Sep 2022
Reporting date
15 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
425

425

Filing date
24 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-266737

S-8

Filing date
10 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Jul 2022
Reporting date
30 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Jul 2022
Reporting date
30 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
30 Jun 2022
Reporting date
29 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
29 Jun 2022
Reporting date
29 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-33093

425

Filing date
21 Jun 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Jun 2022
Reporting date
10 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Jun 2022
Reporting date
10 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Jun 2022
Reporting date
10 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Jun 2022
Reporting date
10 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
14 Jun 2022
Reporting date
10 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .